Nicholas King

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

Jürgen Geisler, Nicholas King, Mitch Dowsett et al. · British Journal of Cancer · 1996 · 341 citations · Full text

Breast Oncology, Oncology, Medicine +11

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

Jürgen Geisler, Nicholas King, Gun Anker et al. · PubMed · 1998 · 316 citations

Bolus Injection, Breast Oncology, Gynecology +17

Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization

Patrick H. McNulty, Nicholas King, Sofia Scott et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2005 · 179 citations

Supplemental Oxygen, Nitric Oxide, Cardiovascular Function +18

ATP concentrations and muscle tension increase linearly with muscle contraction

Jianhua Li, Nicholas King, Lawrence I. Sinoway · Journal of Applied Physiology · 2003 · 133 citations

Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.

A A Daffada, S R Johnston, I. E. Smith et al. · PubMed · 1995 · 106 citations

Breast Oncology, Progesterone Receptor/ps2 Status, Medicine +12